Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

1 passage

referencesuptodate· REFERENCES· item f28_9_28821

REFERENCES Bergqvist E, Sjoberg HE, Hjern B, et al, “Calcitonin in the Treatment of Hypercalcaemic Crisis,” Acta Med Scand , 1972, 192(5):385-9. [PubMed 5083377 ] Cohen V, Jellinek SP, Teperikidis L, et al, “Room-Temperature Storage of Medications Labeled for Refrigeration,” Am J Health-Syst Pharm , 2007, 64(16):1711-15. [PubMed 17687059 ] Lyritis GP, Tsakalakos N, Magiasis B, et al, “Analgesic Effect of Salmon Calcitonin in Osteoporotic Vertebral Fractures: A Double-Blind, Placebo-Controlled Clinical Study,” Calcif Tissue Int , 1991, 49(6):369-72. [PubMed 1818759 ] Pontiroli AE, Pajetta E, Scaglia L, et al, “Analgesic Effect of Intranasal and Intramuscular Salmon Calcitonin in Postmenopausal Osteoporosis: A Double-Blind, Double-Placebo Study,” Aging (Milano) , 1994, 6(6):459-63. Reginster JY, Deroisy R, Lecart MP, et al, “A Double-Blind, Placebo-Controlled, Dose-Finding Trial of Intermittent Nasal Salmon Calcitonin for Prevention of Postmenopausal Lumbar Spine Bone Loss,” Am J Med , 1995, 98(5):452-8. [PubMed 7733123 ] Reginster JY, “Calcitonin for Prevention and Treatment of Osteoporosis,” Am J Med , 1993, 95(5A):44S-47S. [PubMed 8256795 ] Stevenson JC, “Current Management of Malignant Hypercalcemia,” Drugs , 1988, 36(2):229-30. [PubMed 3053127 ] Topic 9182 Version 41.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-125.69.132.100-7288C09AE7-S244013.14]